title: Effects of leukotriene B4 on permeability, prostacyclin and thromboxane release by normal and oxygen-preexposed isolated, perfused rat lungs.
abstract: This study assessed the hemodynamic and permeability effects of exogenous, synthetic leukotriene B4 (LTB4) on normal rat lungs and lungs from rats preexposed to oxygen for 48 h, which were isolated and perfused at constant flow in vitro. Adult, Sprague-Dawley rats were exposed to air or greater than 97% O2 for 48 h. After exposure, their lungs were removed from the thorax, ventilated with normoxic gas, and perfused at 12 ml/min with Krebs-Ringer bicarbonate buffer which contained 5 mM glucose and 3 mg/ml albumin. A total of 5.55 micrograms of synthetic LTB4 was infused in three separate boluses over 15 minutes. Perfusion and airway pressures were monitored, and the lungs release of 6-ketoprostaglandin F1 alpha and thromboxane B2 (TXB2) into the effluent from the pulmonary vasculature was measured by radioimmunoassay. The LTB4 had no measureable effects on pulmonary vascular pressures. LTB4 infusion caused a pronounced increase in permeability, indicated by increased albumin concentrations in alveolar lavage fluid from O2-preexposed lungs. Release of TXB2 from both air- and O2-preexposed lungs was increased after LTB4 infusion, while the change in 6-ketoprostaglandin F1 alpha release was not statistically significant. Both the increase in permeability enhanced TXB2 released after LTB4 infusion were inhibited by 10 microM indomethacin in the perfusate. These data indicate that exogenous LTB4 increases microvascular permeability in O2-exposed lungs in association with increased release of TXB2 into the pulmonary vascular effluent.
authors.affiliation: Birmingham Veterans Administration Medical Center, Alabama.
authors.forename: R M
authors.initials: RM
authors.lastname: Jackson
authors.forename: H S
authors.initials: HS
authors.lastname: Ann
mesh_terms: D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects; D011464:Epoprostenol / Q000378:metabolism*; D006439:Hemodynamics; D007213:Indomethacin / Q000494:pharmacology; D007975:Leukotriene B4 / Q000494:pharmacology*; D008168:Lung / Q000378:metabolism*; D010100:Oxygen / Q000494:pharmacology*; D010477:Perfusion; D051381:Rats; D013931:Thromboxanes / Q000378:metabolism*
chemical_list: D013931:Thromboxanes; D007975:Leukotriene B4; D011464:Epoprostenol; D010100:Oxygen; D007213:Indomethacin